Evidence map›Paper›PMID 31928252›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2020

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase.

Mikhail Krasavin, Raivis Žalubovskis, Aiga Grandāne, Ilona Domračeva, Petr Zhmurov, Claudiu T Supuran

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Carbonic Anhydrase Inhibitors in Oncology.Sub-cellular biochemistry · 2026
    Review
  3. Article
  4. Article
  5. 3Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  6. Aryl derivatives of 3Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  7. 1,2,3-Benzoxathiazine-2,2-dioxides - effective inhibitors of human carbonic anhydrases.Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Thioredoxin-dependent system. Application of inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  14. Review
  15. Onopordopicrin from the new genusJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Coumarin carbonic anhydrase inhibitors from natural sources.Journal of enzyme inhibition and medicinal chemistry · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Mikhail KrasavinDepartment of Chemistry, Saint Petersburg State University, Saint Petersburg, Russian Federation.
Raivis ŽalubovskisLatvian Institute of Organic Synthesis, Riga, Latvia.
Aiga GrandāneLatvian Institute of Organic Synthesis, Riga, Latvia.
Ilona DomračevaLatvian Institute of Organic Synthesis, Riga, Latvia.
Petr ZhmurovDepartment of Chemistry, Saint Petersburg State University, Saint Petersburg, Russian Federation.
Claudiu T SupuranNeurofarba Department, Universita degli Studi di Firenze, Florence, Italy.ORCID http://orcid.org/0000-0003-4262-0323
Latvijas Organiskās Sintēzes Institūts · LVSt Petersburg University · RURiga Technical University · LVUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hypothesis that sulfocoumarin acting as inhibitors of human carbonic anhydrase (CA, EC 4.2.1.1) cancer-associated isoforms

Indexed as

Antigens, NeoplasmAntineoplastic AgentsCarbonic Anhydrase IXCarbonic AnhydrasesCell ProliferationCell SurvivalCoumarinsDose-Response Relationship, DrugDrug Screening Assays, AntitumorEnzyme InhibitorsHumansIsoenzymesMCF-7 CellsMolecular StructureStructure-Activity RelationshipThioredoxin-Disulfide ReductaseAntigens, NeoplasmAntineoplastic AgentsCA9 protein, humanCarbonic Anhydrase IXCarbonic Anhydrasescarbonic anhydrase XIICoumarinsEnzyme InhibitorsIsoenzymesThioredoxin-Disulfide ReductaseAnticancer agentscarbonic anhydrase inhibitionhypoxiaoxidative stressthioredoxin reductase inhibition

Identifiers

PMID31928252
PMCPMC7006680
OpenAlexW3000433028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.